Matthew Dolan | DexCom, Inc. |
Kevin Ronald Sayer | DexCom, Inc. |
Quentin Blackford | DexCom, Inc. |
Steven Robert Pacelli | DexCom, Inc. |
Danielle Antalffy | Leerink Partners LLC |
J. P. McKim | Piper Jaffray & Co. |
Travis Steed | Bank of America Merrill Lynch |
Margaret M. Kaczor | William Blair & Co. LLC |
Jeff D. Johnson | Robert W. Baird & Co., Inc. |
Jayson T. Bedford | Raymond James & Associates, Inc. |
Robert J. Marcus | JPMorgan Securities LLC |
Ryan Blicker | Cowen & Co. LLC |
Joanne Karen Wuensch | BMO Capital Markets (United States) |
Anthony Petrone | Jefferies LLC |
David Ryan Lewis | Morgan Stanley & Co. LLC |
Kyle William Rose | Canaccord Genuity, Inc. |
Steven Lichtman | Oppenheimer & Co., Inc. |
Christopher Pasquale | Guggenheim Securities LLC |
Suraj Kalia | Northland Securities, Inc. |
Isaac Ro | Goldman Sachs & Co. LLC |
Ravi Misra | Berenberg Capital Markets LLC |
Hello and welcome to the DexCom second quarter 2018 earnings release conference. My name is Michelle and I will be your Operator for today's call. At this time, all participants are in a listen-only mode. Later we will conduct a question-and-answer session. Please note that today's conference is being recorded.